Article
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression.
Journal of clinical psychopharmacology - 1 Oct 2012
Jaquenoud Sirot Eveline, Harenberg Sabine, Vandel Pierre, Lima Carlos A Mendonça, Perrenoud Patrick, Kemmerling Klaus, Zullino Daniele F, Hilleret Henriette, Crettol Séverine, Jonzier-Perey Michèle, Golay Kerry Powell, Brocard Muriel, Eap Chin B, Baumann Pierre
Abstract excerpt
Pharmacogenetic tests and therapeutic drug monitoring may considerably improve the pharmacotherapy of depression. The aim of this study was to evaluate the relationship between the efficacy of mirtazapine (MIR) and the steady-state plasma concentrations of its enantiomers and metabolites in moderately to severely depressed patients, taking their pharmacogenetic status into account. Inpatients and outpatients (n =...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
